These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21719339)

  • 21. Update on pathogen reduction technology for therapeutic plasma: an overview.
    Solheim BG; Seghatchian J
    Transfus Apher Sci; 2006 Aug; 35(1):83-90. PubMed ID: 16934528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improving blood safety and patient outcomes with pathogen reduction technology.
    Goodrich RP; Ettinger A; Radziwon PM; Rock G
    Transfus Apher Sci; 2011 Dec; 45(3):229-38. PubMed ID: 22078570
    [No Abstract]   [Full Text] [Related]  

  • 23. Alternative strategies in assuring blood safety: An overview.
    Epstein JS
    Biologicals; 2010 Jan; 38(1):31-5. PubMed ID: 20110174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risks and side effects of therapy with plasma and plasma fractions.
    MacLennan S; Barbara JA
    Best Pract Res Clin Haematol; 2006; 19(1):169-89. PubMed ID: 16377549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacterial contamination in blood components and preventative strategies: an overview.
    Vasconcelos E; Seghatchian J
    Transfus Apher Sci; 2004 Oct; 31(2):155-63. PubMed ID: 15501419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Issues in transfusion therapy in the patient with malignancy.
    Friedberg RC
    Hematol Oncol Clin North Am; 1994 Dec; 8(6):1223-53. PubMed ID: 7860446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Towards bacterial detection in labile blood products].
    Morel P
    Transfus Clin Biol; 2005 Jun; 12(2):215-20. PubMed ID: 15894499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Indications for labile blood products].
    Jeanne M; Rasonglès P
    Rev Prat; 2001 Jun; 51(12):1318-27. PubMed ID: 11503505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TRALI risk reduction: donor and component management strategies.
    Eder AF; Benjamin RJ
    J Clin Apher; 2009; 24(3):122-9. PubMed ID: 19365816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The risk of substitution therapy with blood and blood products].
    Baumgarten R
    Z Arztl Fortbild (Jena); 1994 Jan; 88(1):3-4. PubMed ID: 8154136
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pathogen inactivation technologies: a complex but necessary debate].
    Andreu G; Cazenave JP; Garraud O; Lefrère JJ
    Transfus Clin Biol; 2011 Aug; 18(4):443. PubMed ID: 21783399
    [No Abstract]   [Full Text] [Related]  

  • 32. Transfusion-transmitted bacterial infection: risks, sources and interventions.
    Wagner SJ
    Vox Sang; 2004 Apr; 86(3):157-63. PubMed ID: 15078249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Techniques of preparation and indications of labile blood products].
    Clément S
    Transfus Clin Biol; 2011 Apr; 18(2):250-61. PubMed ID: 21474355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood products.
    Goodrich RP; Doane S; Reddy HL
    Biologicals; 2010 Jan; 38(1):20-30. PubMed ID: 20093041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pathogen reduction: a clinician view].
    Socié G
    Transfus Clin Biol; 2011 Aug; 18(4):491-2. PubMed ID: 21715208
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pathogen reduction for platelets: a debate].
    Moncharmont P; Py JY
    Transfus Clin Biol; 2011 Aug; 18(4):498-501. PubMed ID: 21715209
    [No Abstract]   [Full Text] [Related]  

  • 37. Globalisation and blood safety.
    Farrugia A
    Blood Rev; 2009 May; 23(3):123-8. PubMed ID: 19081166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and significance of the bacterial contamination of blood components.
    Blajchman MA
    Dev Biol (Basel); 2002; 108():59-67. PubMed ID: 12220143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Warm fresh whole blood transfusion for severe hemorrhage: U.S. military and potential civilian applications.
    Spinella PC
    Crit Care Med; 2008 Jul; 36(7 Suppl):S340-5. PubMed ID: 18594261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beyond HIV, HBV and HCV--how to deal with other viruses?
    Minor PD
    Dev Biol (Basel); 2002; 108():15-9. PubMed ID: 12220138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.